FDA Adverse Event Injury Summary report: N

PROLENE POLYPROPYLENE MESH

MDR report key: 3181923 · Received June 21, 2013

Report

Report Number
2210968-2013-07491
Event Type
Injury
Date Received
June 21, 2013
Report Date
May 28, 2013
Manufacturer
ETHICON, INC.
Product Code
FTL
PMA / PMN Number
K001122
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE AND MESH WAS IMPLANTED (B)(6) 2005 IN ORDER TO TREAT GRADE 2-3 CYSTOCELE AND VAGINAL CUFF PROLAPSE CONCURRENTLY WITH POSTERIOR IVS TUNNELER, VAGINAL CUFF SUSPENSION, AND A CYSTOSCOPY. IT WAS REPORTED THAT THE PATIENT UNDERWENT A HYSTERECTOMY AND PUBOVAGINAL SLING IN AUGUST 2004. DUE TO RECURRENT STRESS INCONTINENCE THE PATIENT UNDERWENT PUBOVAGINAL SLING IMPLANTATION WITH BOSTON SCIENTIFIC ADVANTAGE ON (B)(6) 2007. NO ADDITIONAL INFORMATION WAS PROVIDED. (B)(4).

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT FOLLOWING INSERTION THE PATIENT EXPERIENCED RECURRENT CYSTOCELE, RECTOCELE AND ENTEROCELE.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2005 AND A MESH WAS IMPLANTED. IT WAS ALSO REPORTED THAT THE PATIENT UNDERWENT A SURGICAL PROCEDURE ON (B)(6) 2007 AND ADVANTAGE POLYPROPYLENE MESH BY BOSTON SCIENTIFIC WAS IMPLANTED. THE PATIENT EXPERIENCED PAIN, EROSION OF INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE AND HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
283143 PROLENE POLYPROPYLENE MESH MESH FTL ETHICON, INC. NA UGE298

Patients

Seq Age Sex Outcome Treatment
1 60 YR Required Intervention